亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳市思科達生物技術有限公司  

專業經營化學標準品，對照品
搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人：楊森
  • 電話：0755-89218244
  • 郵件：lq@szskerd.com
  • 傳真：0755-28984072
  • QQ：793285927
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 替比培南酯
替比培南酯
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 深圳市思科達生物技術有限公司
過期 長期有效
更新 2014-12-02 13:09
 
詳細信息
 產品名稱：替比培南酯 雜質 標準品 對照品 161715-24-8

產品關鍵詞：替比培南酯 雜質 標準品 對照品 161715-24-8

替比培南酯                                            Tebipenem pivoxil                       100mg

替比培南酯雜質 P2                              Tebipenem pivoxil Impurity P2  10mg/25mg/50mg

替比培南酯雜質 P6                              Tebipenem pivoxil Impurity P6  10mg/25mg/50mg

替比培南酯雜質 P8                              Tebipenem pivoxil Impurity P8  10mg/25mg/50mg

替比培南酯雜質 P9                              Tebipenem pivoxil Impurity P9  10mg/25mg/50mg
©2025 深圳市思科達生物技術有限公司 版權所有   技術支持：化工網   訪問量:12469  
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |